Viewing Study NCT00812292


Ignite Creation Date: 2025-12-24 @ 3:50 PM
Ignite Modification Date: 2026-01-31 @ 8:37 AM
Study NCT ID: NCT00812292
Status: COMPLETED
Last Update Posted: 2011-06-09
First Post: 2008-12-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: TMC278-TiDP38-C145: A Bioavailability Study in Healthy Adult Volunteers to Evaluate 3 Pediatric Formulations of TMC278 (a Solution, a Suspension, and Granules) Compared to an Adult Tablet Formulation
Sponsor: Tibotec Pharmaceuticals, Ireland
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module